Heron Therapeutics Ownership | Who Owns Heron Therapeutics?
Heron Therapeutics Ownership Summary
Heron Therapeutics is owned by 79.70% institutional investors, 0.71% insiders, and 19.59% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.67% of HRTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.09% of its assets in Heron Therapeutics shares.
HRTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Heron Therapeutics | 79.70% | 0.71% | 19.59% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rubric capital management lp | 26.71M | 17.67% | $93.50M |
| Vanguard group | 8.62M | 5.70% | $30.16M |
| Blackrock | 8.33M | 5.51% | $29.14M |
| Adage capital partners gp | 7.60M | 5.03% | $26.60M |
| Velan capital investment management lp | 6.99M | 4.62% | $24.45M |
| Franklin resources | 6.33M | 4.18% | $22.15M |
| State street | 5.28M | 3.49% | $18.48M |
| Tejara capital | 4.19M | 2.77% | $14.66M |
| Palisade capital management, lp | 4.05M | 2.68% | $14.17M |
| D. e. shaw | 3.86M | 2.56% | $13.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Velan capital investment management lp | 6.99M | 14.01% | $24.45M |
| Tejara capital | 4.19M | 5.33% | $14.66M |
| Jw asset management | 2.29M | 3.31% | $8.02M |
| Richmond brothers | 356.56K | 2.47% | $1.25M |
| Rubric capital management lp | 26.71M | 2.45% | $93.50M |
| Orchard capital management | 2.24M | 2.37% | $7.85M |
| Congress park capital | 1.58M | 2.22% | $5.52M |
| Cm management | 300.00K | 0.96% | $1.05M |
| Monaco asset management sam | 1.51M | 0.84% | $5.30M |
| Tang capital management | 1.85M | 0.66% | $6.47M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 7.60M | 0.05% | 4.69M |
| State street | 5.28M | 0.00% | 2.84M |
| Marshall wace, llp | 1.76M | 0.01% | 1.27M |
| D. e. shaw | 3.86M | 0.01% | 1.17M |
| Blackrock | 8.33M | 0.00% | 1.04M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -6.51M |
| Millennium management | 1.43M | 0.00% | -1.73M |
| Clearline capital lp | 1.50M | 0.14% | -1.28M |
| Essex investment management | - | - | -695.99K |
| Renaissance | 1.99M | 0.01% | -412.69K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| State of wisconsin investment board | 143.00K | 0.00% | 143.00K | $500.51K |
| Corebridge financial | 63.16K | 0.00% | 63.16K | $221.06K |
| Mirae asset global etfs | 61.76K | 0.00% | 61.76K | $215.29K |
| Group one trading | 54.25K | 0.00% | 54.25K | $189.88K |
| Synovus financial | 31.85K | 0.00% | 31.85K | $111.47K |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -9.00 |
| Lindbrook capital | -16.00 |
| Gps wealth strategies group | -72.00 |
| Financial gravity asset management | -75.00 |
| Rothschild investment | -85.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 175 | -9.79% | 121,805,039 | -6.02% | 79 | 1.08% | 87 | -23.01% | 38 | -2.56% |
| Jun 30, 2024 | 194 | 17.58% | 129,609,462 | 8.61% | 85 | 1.36% | 113 | 59.15% | 39 | -17.02% |
| Mar 31, 2024 | 165 | 5.77% | 119,336,211 | 6.43% | 79 | 1.33% | 71 | -4.05% | 47 | 27.03% |
| Dec 31, 2023 | 156 | 11.43% | 112,127,927 | -4.94% | 77 | 0.80% | 74 | 42.31% | 37 | -5.13% |
| Sep 30, 2023 | 140 | -6.04% | 117,952,089 | 19.93% | 98 | 1.45% | 52 | -14.75% | 39 | -15.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.68M | 3.09% | - |
| iShares Russell 2000 ETF | 3.04M | 2.00% | -6.83K |
| Biotech Growth Ord | 2.58M | 1.70% | 2.58M |
| Palisade Small Cap Core Equity | 2.47M | 1.63% | -98.19K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.18M | 1.44% | -197.17K |
| Orchard US Small Cap Value USD Instl 1 | 2.02M | 1.33% | - |
| Orchard Small Cap Value ESG | 2.02M | 1.33% | 1.99M |
| Franklin US Small Cap Growth Equity | 1.80M | 1.19% | - |
| Fidelity Small Cap Index | 1.20M | 0.79% | -26.07K |
| iShares Russell 2000 Value ETF | 1.00M | 0.66% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2023 | Forbes William P | EVP, Chief Development Officer | Buy | $27.25K |
| Nov 16, 2023 | Forbes William P | EVP, Chief Development Officer | Buy | $46.99K |
| Nov 16, 2023 | Collard Craig A | Chief Executive Officer | Buy | $137.97K |
| Nov 16, 2023 | Duarte Ira | EVP, Chief Financial Officer | Buy | $75.60K |
| Jul 21, 2023 | Morgan Adam | - | Buy | $3.41M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 4 | - |
HRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools